Tris Pharma Inc is a privately‑owned biopharmaceutical company focused on developing and commercializing innovative medicines for ADHD, spectrum disorders, anxiety, pain, and addiction. The company holds 150 U.S. and international patents and markets several branded ADHD products while licensing its portfolio in U.S. and international markets. With a robust pipeline spanning neuroscience and other therapeutic categories, Tris Pharma leverages proprietary science and technology to address unmet patient needs.
Responsible for strategic leadership and operational oversight of global pharmacovigilance and drug safety programs for marketed and investigational products.
Tris Pharma Inc is a privately‑owned biopharmaceutical company focused on developing and commercializing innovative medicines for ADHD, spectrum disorders, anxiety, pain, and addiction. The company holds 150 U.S. and international patents and markets several branded ADHD products while licensing its portfolio in U.S. and international markets. With a robust pipeline spanning neuroscience and other therapeutic categories, Tris Pharma leverages proprietary science and technology to address unmet patient needs.